Увійти

Готові списки джерел за темами / Jia tai fu ci

Зміст

Статті в журналах
Дисертації
Книги

Добірка наукової літератури з теми "Jia tai fu ci"

Автор: Grafiati

Опубліковано: 25 липня 2024

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Jia tai fu ci".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Jia tai fu ci"

1

Milatz, F., I. Liedmann, M. Niewerth, et al. "THU0512 HEALTH RISK BEHAVIORS IN ADOLESCENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN THE COURSE OF DISEASE: RESULTS OF THE GERMAN MULTICENTER INCEPTION COHORT (ICON)." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 494.1–495. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2155.

Повний текст джерела

Анотація:

Background:Health risk behaviors (HRB) are defined as specific forms of behavior associated with increased susceptibility to a specific disease or ill health on the basis of epidemiological or social data. The social implications of HRB include being able to use them as a way to gain respect and acceptance from peers, establishing independence from parents, or providing a subjective feeling of maturity and adequate stress management [1].Objectives:Since chronically ill adolescents such as those suffering from JIA can develop a HRB that is challenging for optimal care the aim of this study was

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Liao, Yueh-Hsiang, Jaung-Geng Lin, Cheng-Chieh Lin, Chin-Chuan Tsai, Hui-Lien Lai, and Tsai-Chung Li. "Traditional Chinese Medicine Treatment Associated with Female Infertility in Taiwan: A Population-Based Case-Control Study." Evidence-Based Complementary and Alternative Medicine 2020 (December 12, 2020): 1–11. http://dx.doi.org/10.1155/2020/3951741.

Повний текст джерела

Анотація:

Background. Traditional Chinese medicine (TCM) for the treatment of female infertility remains ambiguous. The aim of the present case-control study was to examine the association between TCM treatment and successful pregnancy among infertile women. Methods. This population-based case-control study included the data from 2,627 infertile women with successful pregnancy and 2,627 infertile women without successful pregnancy using datasets from the Longitudinal Health Insurance Database 2000 of the National Health Insurance Research Database during 2000–2010. The odds ratios (ORs) and 95% confiden

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Tsang, Tracey W., Michael R. Kohn, Chin Moi Chow, and Maria Antoinette Fiatarone Singh. "Kung Fu Training Improves Physical Fitness Measures in Overweight/Obese Adolescents: The “Martial Fitness” Study." Journal of Obesity 2010 (2010): 1–10. http://dx.doi.org/10.1155/2010/672751.

Повний текст джерела

Анотація:

Aim. To examine the efficacy of a six-month Kung Fu (KF) program on physical fitness in overweight/obese adolescents.Methods. Subjects were randomly assigned to the KF or sham exercise (Tai Chi, TC) control group. Physical measurements in cardiovascular fitness and muscle fitness occurred at baseline and after 6 months of training thrice weekly.Results. Twenty subjects were recruited. One subject was lost to follow-up, although overall compliance to the training sessions was46.7±27.8%. At follow-up, the cohort improved in absolute upper (P=.002) and lower (P=.04) body strength, and upper body

Стилі APA, Harvard, Vancouver, ISO та ін.

4

van Leeuwen, Merle, Sandra van den Belt-Dusebout, Jia Ning Zhuchen, et al. "Abstract P3-03-29: Calcification characteristics in women with benign breast disease and the risk of subsequent breast cancer: a case-control study." Clinical Cancer Research 31, no. 12_Supplement (2025): P3–03–29—P3–03–29. https://doi.org/10.1158/1557-3265.sabcs24-p3-03-29.

Повний текст джерела

Анотація:

Abstract Background: Benign breast disease (BBD) is commonly detected in women participating in breast cancer screening programs and comprises a diverse group of lesions. The clinical significance of BBD lies in its association with an increased risk of developing breast cancer, which depends on the histological subtype. Calcifications, frequently observed in mammographic screenings, are critical in the detection and diagnosis of both benign and malignant breast conditions. While many calcifications are benign, some patterns are indicative of ductal carcinoma in situ (DCIS) or invasive breast

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Zhang, Wenjuan, Xi Jin, Huiping Li, et al. "Abstract P2-09-17: Precision medicine based on similarity network fusion (SNF) subtypes of multi-omics in CDK4/6 inhibitor failed HR+/ HER2- advanced breast cancer: the Linux trial." Clinical Cancer Research 31, no. 12_Supplement (2025): P2–09–17—P2–09–17. https://doi.org/10.1158/1557-3265.sabcs24-p2-09-17.

Повний текст джерела

Анотація:

Abstract Background: Endocrine therapy combined with CDK4/6 inhibitor represents the first-line standard treatment for HR+/HER2- metastatic breast cancer. However, there is no well-defined standard of care following resistance to CDK4/6 inhibitors. In previous study, we innovatively classified HR+/HER2- breast cancers into four subtypes using large-scale multi-omics data and similarity network fusion (SNF) (Nat Genet. 2023) : SNF1 for canonical luminal, SNF2 for immunogenic, SNF3 for proliferative and SNF4 for receptor tyrosine kinase (RTK)-driven. This platform trial aimed to evaluate the eff

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Liang, Yan, Jing Liu, Tao Luo, et al. "Abstract P5-10-01: Phase 2 study of anlotinib combined with taxanes and lobaplatin in the neoadjuvant treatment of triple-negative breast cancer: efficacy, safety and biomarker analysis from the SWH-B006 (neoALTALL) trial." Cancer Research 83, no. 5_Supplement (2023): P5–10–01—P5–10–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-10-01.

Повний текст джерела

Анотація:

Abstract Background: Anlotinib, a novel multi-target tyrosine kinase inhibitor that effectively inhibits VEGFR, PDGFR, FGFR, c-KIT, c-MET, and RET, monotherapy has been proven effective in HER-2 negative metastatic breast cancer, but its efficacy in early-stage triple-negative breast cancer (TNBC) is unknown. This phase 2 study aims to evaluate the efficacy and safety of adding anlotinib to neoadjuvant chemotherapy in patients (pts) with primary TNBC. Methods: Pts with clinical stage II/III TNBC were to be treated with 5 cycles of anlotinib (12mg, d1-14, q3w) plus 6 cycles of taxanes (docetaxe

Стилі APA, Harvard, Vancouver, ISO та ін.

7

JIA, XIAOFAN, CAIGUO ZHANG, FRAN DONG та ін. "17-OR: Novel Autoantibodies Specific to β-Cell Surface Extracellular Epitope of ZnT8 Predict Progression to Type 1 Diabetes". Diabetes 74, Supplement_1 (2025). https://doi.org/10.2337/db25-17-or.

Повний текст джерела

Анотація:

Introduction and Objective: Novel autoantibodies to extracellular epitopes of ZnT8 (ZnT8ecA) on the β-cell surface have been recently identified as the earliest detectable autoantibody in children followed from birth. This study aims to determine its prediction for T1D progression. Methods: ZnT8ecA were measured in the DAISY birth cohort participants (n=209) who were confirmed positive for at least one standard islet autoantibody (IAb), including IAA, GADA, IA-2A or ZnT8A. Sera collected at and before the appearance of the first standard IAb were tested for ZnT8ecA. The cut-off of ZnT8ecA assa

Стилі APA, Harvard, Vancouver, ISO та ін.

8

許, 東海. "仙遊•貴遊•夢遊———李白供奉翰林的謫仙身影及其遇合困境". 人文中國學報, 1 грудня 2016, 61–92. http://dx.doi.org/10.24112/sinohumanitas.232108.

Повний текст джерела

Анотація:

LANGUAGE NOTE | Document text in Chinese; abstract also in English. 本文透過李白入京供奉翰林前後的相關觀照，大體可以略窺李白追夢長安的謫仙身影背後，存在著漢代賦家馬、揚及東方朔等人的深刻文化召唤；至於藉由李白入京之前泰山仙遊書寫的帝王封禪及其遇合隱喻，與供奉翰林之際《清平調三首》的始於瑶臺王母及巫山神女的相關遇合隱喻，與去朝離京之後夢遊天姥書寫的長安驚夢，適可映現李白由追夢長安歷程仙遊、貴遊與夢遊前後鋪陳的謫仙三部曲。 Studying Li Bai’s works and circumstances before and after his service at the Hanlin Academy, this essay observes a deep-rooted cultural echo of the two fu writers of the Han, Sima Xiangru (179 BC-117 BC) and Yang Xiong (53 BC-18 AD), as well as that of Dongfang Shuo (ca. 154 BC-93 BC), behind Li’s reminiscence of his adventure to Chang’an

Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Jia tai fu ci"

1

I-ChiaChen and 陳怡嘉. "A Study of Shuo Tang Gu Ci “Story of Qin Qiong’s Visit and Disturbance in Tai Yuan Fu with illustration”." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/17243807172670894329.

Повний текст джерела

Анотація:

碩士<br>國立成功大學<br>中國文學系碩博士班<br>98<br>The ancient history stories about the heroes fought for power at the end of Sui Dynasty and at the beginning of Tang Dynasty had a great development among Chinese classic novels, dramas, and other forms of literature. For example, “Shuo Tang Quan Zhuan” which was collated by Yun Hu Yu Sou of Cing Dynasty (abbr. “Shuo Tang”) was very popular among people. Many stories of Folk Literature were based on its plots. When it comes to the study of “Shuo Tang”, many researchers were focus on contrasting the different plots of “Shuo Tang” and other series novels of Sui

Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Jia tai fu ci"

1

Xia, Xianyun. 贾太傅祠志. 定王台志. 南岳二贤祠志. Yuelu shu she, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Liao, Xiuguang. Guo yin dui zhao Tai yu zi hui: Fu zhu wai lai yin biao, jia lie jian shi li ci. Li chang chu ban she, 1996.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Gengyuan, Wei, and Xue Lian, eds. Wan jia ci fu. Zhongguo she hui chu ban she, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Yanliang, Wang, Zhao Liang, and Jin Muzhen, eds. Ri Han xiang sheng xing tai fu ci ci dian. Zhi shi chu ban she, 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Liu, Xue. Ci ren jia ting yu Song ci chuan cheng: Yi fu zi ci ren wei zhong xin. Bai hua zhou wen yi chu ban she, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Jingshan, Wang, ed. Tai Gang Ao ji hai wai Hua wen zuo jia ci dian. Ren min wen xue chu ban she, 2003.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

You, Xingbo. Fu sheng ci di: Xun ji "Tang Song ba da jia". She hui ke xue wen xian chu ban she, 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

1928-, Lin Zhu, ed. Da shi, ci fu, ai: Liang Qichao jia shu xuan ji. San lian shu dian (Xianggang) you xian gong si, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Hui, He. Yinxu wang bu ci gui fu jia wen li yan jiu. Zhongguo she hui ke xue chu ban she, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Zhao shi jia pu bian wei hui. Zhao shi jia pu: Xunzhong Cun xi tai hou ci tang zhi xi. s.n.], 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!